배아줄기세포로부터 신경교전구세포, 성상세포 및 희소돌기 아교세포로의 분화방법
    5.
    发明公开
    배아줄기세포로부터 신경교전구세포, 성상세포 및 희소돌기 아교세포로의 분화방법 有权
    从胚胎干细胞分化玻璃原细胞,阿斯利康和奥利膦酸酯的方法

    公开(公告)号:KR1020150051122A

    公开(公告)日:2015-05-11

    申请号:KR1020140024179

    申请日:2014-02-28

    CPC classification number: C12N5/0618

    Abstract: 본발명은배아줄기세포로부터신경교전구세포, 성상세포및 희소돌기아교세포로의분화방법에관한것이다. 본발명에따른배아줄기세포로부터신경교전구세포, 성상세포및 희소돌기아교세포로의분화방법을이용할경우, 수득된신경교전구세포의지속적인배양이가능하며, 상기신경교전구세포는성상세포및 희소돌기아교세포로의분화가가능하여이와관련된독성물질의스크리닝및 독성평가에유용하게이용될수 있다.

    Abstract translation: 本发明涉及诱导胚胎干细胞将其分化成胶质祖细胞,星形胶质细胞和少突胶质细胞的方法。 根据本发明的一个实施方案,该方法包括以下步骤:1)培养胚胎干细胞以形成胚状体; 2)将胚状体分离成单个细胞并培养分离的单细胞以诱导神经干细胞的产生; 3)另外培养神经干细胞,将培养的神​​经干细胞分离成单细胞,将分离的神经干细胞传代培养5〜40次。 当使用根据本发明的方法时,可以连续培养获得的胶质祖细胞并诱导胶质祖细胞分化为星形胶质细胞和少突胶质细胞,从而有效地用于筛选与细胞有关的毒性物质并评估毒性 。

    소디움 부티레이트를 처리하여 수득된 완전 역분화 줄기세포주
    6.
    发明公开
    소디움 부티레이트를 처리하여 수득된 완전 역분화 줄기세포주 无效
    通过处理丁酸钠获得的完全诱导的细胞干细胞

    公开(公告)号:KR1020140082021A

    公开(公告)日:2014-07-02

    申请号:KR1020120150936

    申请日:2012-12-21

    CPC classification number: C12N5/0696

    Abstract: The present invention relates to a complete induced pluripotent stem cell obtained by treating sodium butyrate and a treating method thereof which contain a process of treating the sodium butyrate onto the complete induced pluripotent stem cell. According to the present invention, the production method can be effectively used for research of the relevant fields, as a partial induced pluripotent stem cell having an interval characteristic of a somatic cell and a stem cell can be efficiently converted into the complete induced pluripotent stem cell.

    Abstract translation: 本发明涉及通过处理丁酸钠而获得的完全诱导的多能干细胞及其治疗方法,其包含将丁酸钠处理到完全诱导的多能干细胞上的方法。 根据本发明,生产方法可以有效地用于相关领域的研究,因为具有体细胞间隔特征的部分诱导多能干细胞和干细胞可以有效地转化为完全诱导的多能干细胞 。

    골수암 진단용 마커 조성물
    7.
    发明公开
    골수암 진단용 마커 조성물 有权
    用于诊断骨髓瘤的标记物组合物

    公开(公告)号:KR1020140082016A

    公开(公告)日:2014-07-02

    申请号:KR1020120150885

    申请日:2012-12-21

    CPC classification number: C12N15/11 C12Q1/6844 C12Q1/6886 C12Q2600/154

    Abstract: The present invention relates to a marker composition for diagnosis of bone marrow cancer and a kit and a method for diagnosis of bone marrow cancer including the marker. The marker composition of the present invention amplifies a certain area where CpG area of the gene BCL11a, RB1, GLIS2 and ABI2 is included, in order to compare similarities and differences of the methylation level of the gene. Hence, the present invention can effectively be used to promptly and accurately diagnose bone marrow cancer including T-cell lymphoma, B-cell lymphoma and leukemia.

    Abstract translation: 本发明涉及用于诊断骨髓癌的标记组合物和用于诊断包括该标记物的骨髓癌的试剂盒和方法。 为了比较基因的甲基化水平的相似度和差异,本发明的标记物组合物扩增了包含基因BCL11a,RB1,GLIS2和ABI2的CpG面积的某一区域。 因此,本发明可以有效地用于及时,准确地诊断包括T细胞淋巴瘤,B细胞淋巴瘤和白血病在内的骨髓癌。

Patent Agency Ranking